Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 566

Protein Kinase C promotes peroxisome biogenesis and peroxisome–endoplasmic reticulum interaction

Regulatory T cells (Treg cells) are a specialized subgroup of immune cells that play a central role in the human immune system. These cells can suppress erroneous and therefore harmful immune reactions that can lead to autoimmune diseases, for example. Furthermore, they actively promote the regeneration of tissue after injuries and thus orchestrate the wound healing process.

To this end, Treg cells can release tissue-healing substances and support regenerative cells such as tissue stem cells. They therefore cooperate with both immune and non-immune cells during tissue healing. These diverse functions make Treg cells attractive candidates for therapeutic use, for example, to promote tissue function after acute or chronic inflammation.

To support wound healing processes in the body, Treg cells must develop into so-called tissue-Treg cells. This development process is still poorly understood, and a better understanding is necessary to be able to use Treg cells in the treatment of diseases.

Autonomous gallbladder removal: Robot performs first realistic surgery without human help

A robot trained on videos of surgeries performed a lengthy phase of a gallbladder removal without human help. The robot operated for the first time on a lifelike patient, and during the operation, responded to and learned from voice commands from the team—like a novice surgeon working with a mentor.

The robot performed unflappably across trials and with the expertise of a skilled human surgeon, even during unexpected scenarios typical in real-life medical emergencies.

The work, led by Johns Hopkins University researchers, is a transformative advancement in surgical robotics, where robots can perform with both mechanical precision and human-like adaptability and understanding.

The AI Revolution In Healthcare: How Data Science Is Transforming Drug Discovery And Medical Diagnosis

Going forward, AI has the potential to help balance needs across regions, ensuring care delivery doesn’t compromise chronic or long-term care in the face of emergencies.

Ethical Considerations And Systemic Impact

While AI holds significant promise in healthcare, its implementation must be approached thoughtfully. Challenges such as bias in training data, lack of interoperability and concerns around patient consent and data privacy (particularly under HIPAA) need to be proactively addressed. Effective deployment of AI requires close collaboration between policymakers, clinicians and technologists to establish standards that ensure equitable and inclusive outcomes.

Genetic test predicts obesity in childhood

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment strategies such as lifestyle change, surgery and medications are not universally available or effective.

By drawing on genetic data from over five million people, an international team of researchers has created a genetic test called a (PGS) that predicts adulthood obesity already in early childhood. This finding could help to identify children and adolescents at higher genetic risk of developing obesity, who could benefit from targeted preventative strategies, such as lifestyle interventions, at a younger age.

“What makes the score so powerful is its ability to predict, before the age of five, whether a child is likely to develop obesity in adulthood, well before other risk factors start to shape their weight later in childhood. Intervening at this point can have a huge impact,” says Assistant Professor Roelof Smit from the NNF Center for Basic Metabolic Research (CBMR) at the University of Copenhagen and lead author of the research published in Nature Medicine.

Genetically modified gut bacteria show promise for combating kidney stones in clinical trial

The human gut microbiome has been shown to impact health in a myriad of ways. The type and abundance of different bacteria can impact everything from the immune system to the nervous system. Now, researchers at Stanford University are taking advantage of the microbiome’s potential for fighting disease by genetically modifying certain bacteria to reduce a substance that causes kidney stones. If scientists are successful at modifying gut bacteria, this can lead to therapeutic treatments for a wide range of diseases.

However, the study, published in Science, shows that this is not a simple task. The researchers used the bacterium Phocaeicola vulgatus, which is already found in the microbiome of humans, and modified it to break down and also to consume porphyran, a nutrient derived from seaweed. The porphyran was used as a way to control the population of Phocaeicola vulgatus by either adding more porphyran or reducing the amount, which should kill off the bacteria due to a lack of food.

The study was made up of three parts: one testing the modified bacteria on rats, one trial with healthy humans and one trial on people with enteric hyperoxaluria (EH). EH is a condition in which the body absorbs too much oxalate from food, leading to and other kidney issues, if not treated.

/* */